Evidence map›Paper›PMID 33521447›Full record

ArticleACS omega2021

Rosuvastatin Attenuates Rheumatoid Arthritis-Associated Manifestations via Modulation of the Pro- and Anti-inflammatory Cytokine Network: A Combination of

Sumera Qasim, Alamgeer, Saima Kalsoom, Muhammad Shahzad, Ishfaq Ali Bukhari, Fahim Vohra, Sibtain Afzal

RetractedOpen access · goldAbstract readRetracted Publication
In one paragraph

Article in ACS omega, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. ACS omega · 2024
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. An Expert Opinion on the Role of the Rosuvastatin/Amlodipine Single Pill Fixed Dose Combination in Cardiovascular Prevention.High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension · 2023
    Article
  17. Article
  18. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 4 countries.

Sumera QasimCollege of Pharmacy, Jouf University, Sakaka, Aljouf 2014, Saudi Arabia.
AlamgeerPunjab University College of Pharmacy, University of the Punjab, Lahore 54590, Pakistan.
Saima KalsoomSA-CIRBS International Islamic University, Islamabad 44000, Pakistan.
Muhammad ShahzadDepartment of Pharmacology, University of Health Sciences, Lahore 54590, Pakistan.
Ishfaq Ali BukhariDepartment of Pharmacology, College of Medicine, King Saud University Riyadh, Riyadh 11451, Saudi Arabia.
Fahim VohraDepartment of Prosthetic Dental Sciences, College of Dentistry, King Saud University, Riyadh 11451, Saudi Arabia.
Sibtain AfzalImmunology Research center, College of Medicine, King Saud University Riyadh, Riyadh 11451, Saudi Arabia.
King Saud University · SAInternational Islamic University, Islamabad · PKJouf University · SAUniversity of Health Science · KHUniversity of the Punjab · PK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The current investigation employed rosuvastatin for evaluation as an antiarthritic agent by

Identifiers

PMID33521447
PMCPMC7841959
OpenAlexW3124767859

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.